Search Results - C. Hewison
- Showing 1 - 2 results of 2
-
1
Urgent request for pretomanid label expansion to align with WHO guidelines and improve treatment accessibility and efficacy by L. Kuksa, C. Andrejak, B. Haecker, G. Bothamley, A. Calcagno, D.M. Cirillo, R. Duarte, R. Fatima, G. Ferlazzo, L. Guglielmetti, G. Günther, C. Hewison, C.R. Horsburgh, T. Jäger, Y. Kalancha, R. Otto-Knapp, K. Kranzer, T. Lillebaek, G. Marks, K. Middelkoop, I. Motta, V. Rabinova, P. Sommerfeld, P. Tattevin, C. Lange
Published in IJTLD Open (2025-03-01)Get full text
Article -
2
Effectiveness of a bedaquiline, linezolid, clofazimine ‘core’ for multidrug-resistant TB by C. Zeng, M.A. Hernán, L. Trevisi, S. Sauer, C.D. Mitnick, C. Hewison, M. Bastard, P. Khan, K.J. Seung, M.L. Rich, S. Law, M. Kikvidze, O. Kirakosyan, A. Miankou, P. Thit, S. Mamsa, A. Janmohamed, N. Melikyan, S. Ahmed, D. Vargas, A.B. Binegdie, K. Temirova, L. Oyewusi, K. Philippe, S.C. Vilbrun, U. Khan, H. Huerga, M.F. Franke, on behalf of the endTB Observational Study Team
Published in IJTLD Open (2025-05-01)Get full text
Article
